Disclosures for "Targeting Sensory Circuits for Motor Recovery: A Translational Model for Pediatric Stroke"
-
Dr. Corkrum has nothing to disclose.
-
Dr. Carmel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for BackStop Neural. Dr. Carmel has stock in BackStop Neural. Dr. Carmel has stock in SharperSense. Dr. Carmel has received intellectual property interests from a discovery or technology relating to health care.